Trials / Completed
CompletedNCT06029855
Kabat Rehabilitation Versus Mime Therapy on Facial Disability and Synkinesis in Patients of Bell's Palsy
Effects Of Kabat Rehabilitation Versus Mime Therapy On Facial Disability And Synkinesis In Patients Of Bell's Palsy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- University of Lahore · Academic / Other
- Sex
- All
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Bell's palsy, also called idiopathic facial paralysis, is a common cause of unilateral facial paralysis. It is one of the most common neurological disorders of the cranial nerves.
Detailed description
Bell's palsy is an alarming condition of rapid onset, which paralyzes half of the facial muscles. Kabat rehabilitation is a manual resistance technique that promotes a basic pattern of movement through facilitation, inhibition, and resistance of a group of muscles. It increases the functioning and power of facial muscles while Mime therapy results in immediate improvement of function and integrity of facial muscles. It also mitigates synkinesis in Bell's palsy. Both techniques are easy to apply. They are clinically important techniques that are easily understood by patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Kabat Therapy | The participants of group A will receive Kabat Rehabilitation with routine physical therapy. The protocol will be given to the participants for three sessions/week for six weeks. Each session will be of 30 minutes. |
| OTHER | Mime Therapy | The participants of group B will receive Mime Therapy in addition to routine physical therapy. The protocol will be given to the participants once a week for six weeks, while physical therapy will be given on alternate days. Each session will be of 30 minutes. |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2023-09-30
- Completion
- 2023-10-15
- First posted
- 2023-09-08
- Last updated
- 2025-03-28
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06029855. Inclusion in this directory is not an endorsement.